Home › Funds › BAKER BROS. ADVISORS LP › SMMT

BAKER BROS. ADVISORS LP position in SMMT

SUMMIT THERAPEUTICS INC · Health Care

BAKER BROS. ADVISORS LP reported holding 32,786,348 shares of SMMT (SUMMIT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$554.4M, representing 2.68% of its reported portfolio and ranking #10 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed SMMT holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)32.79M sh
Reported value held$554.42M
Portfolio Weight2.68%
First reportedQ3 2023
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How BAKER BROS. ADVISORS LP's SMMT position evolved

BAKER BROS. ADVISORS LP first disclosed a stake in SMMT in Q3 2023 at 3,140,473 shares (US$5.9M). The position peaked in Q2 2025 at 33,722,974 shares, worth US$717.6M. Across 11 filings, BAKER BROS. ADVISORS LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 32,786,348 shares valued at US$554.4M. Notable position changes include a 38% increase in Q2 2025 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.14M $5.87M New
Q2 2024 23.22M $181.13M New
Q3 2024 24.42M $534.90M Add
Q4 2024 24.42M $435.86M Hold
Q1 2025 24.42M $471.16M Hold
Q2 2025 33.72M $717.62M Add
Q3 2025 33.72M $696.72M Hold
Q4 2025 36.39M $636.48M Add
Q1 2026 36.39M $689.97M Hold
Q2 2026 32.79M $477.70M Reduce
Q3 2026 32.79M $554.42M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SMMT and 13F data

SMMT (SUMMIT THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in SMMT — the largest reported positions include Kynam Capital Management, LP (US$50.7M), Bellevue Group AG (US$35.7M), Affinity Asset Advisors, LLC (US$28.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SMMT

All SMMT fund holders →

FAQ

How long has BAKER BROS. ADVISORS LP held SMMT?

BAKER BROS. ADVISORS LP has disclosed SMMT holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is BAKER BROS. ADVISORS LP's current position in SMMT?

As of Q3 2026, BAKER BROS. ADVISORS LP holds 32.79M shares of SMMT (SUMMIT THERAPEUTICS INC), valued at $554.42M, representing 2.68% of its reported portfolio and ranking #10.

Has BAKER BROS. ADVISORS LP been buying or selling SMMT?

In the latest 13F filing (Q3 2026), BAKER BROS. ADVISORS LP held unchanged its position in SMMT. The position peaked in Q2 2025 at 33.72M shares.

Which other funds hold SMMT?

Other major institutional holders of SMMT include Kynam Capital Management, LP, Bellevue Group AG, Affinity Asset Advisors, LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.